share_log

Biofrontera Shares Are Trading Higher After the Company Announced Top-line Results in Its Phase 3 Study of the Use of Ameluz With the BF-RhodoLED Lamp in the Treatment of SBCC.

Benzinga ·  Nov 1 00:14
Biofrontera Shares Are Trading Higher After the Company Announced Top-line Results in Its Phase 3 Study of the Use of Ameluz With the BF-RhodoLED Lamp in the Treatment of SBCC.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment